###begin article-title 0
###xml 118 144 118 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 118 144 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection
###end article-title 0
###begin p 1
###xml 32 46 32 46 <email xmlns:xlink="http://www.w3.org/1999/xlink">dieli@unipa.it</email>
CORRESPONDENCE Francesco Dieli: dieli@unipa.it
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 152 178 152 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 195 198 195 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 291 306 291 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 815 818 804 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1029 1032 1018 1021 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1075 1090 1064 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 1233 1248 1222 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 152 178 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 291 306 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
###xml 828 832 <span type="species:ncbi:10090">mice</span>
###xml 1033 1037 <span type="species:ncbi:10090">mice</span>
###xml 1075 1090 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1233 1248 <span type="species:ncbi:1773">M. tuberculosis</span>
D6 is a decoy and scavenger receptor for inflammatory CC chemokines. D6-deficient mice were rapidly killed by intranasal administration of low doses of Mycobacterium tuberculosis. The death of D6-/- mice was associated with a dramatic local and systemic inflammatory response with levels of M. tuberculosis colony-forming units similar to control D6-proficient mice. D6-deficient mice showed an increased numbers of mononuclear cells (macrophages, dendritic cells, and CD4 and CD8 T lymphocytes) infiltrating inflamed tissues and lymph nodes, as well as abnormal increased concentrations of CC chemokines (CCL2, CCL3, CCL4, and CCL5) and proinflammatory cytokines (tumor necrosis factor alpha, interleukin 1beta, and interferon gamma) in bronchoalveolar lavage and serum. High levels of inflammatory cytokines in D6-/- infected mice were associated with liver and kidney damage, resulting in both liver and renal failure. Blocking inflammatory CC chemokines with a cocktail of antibodies reversed the inflammatory phenotype of D6-/- mice but led to less controlled growth of M. tuberculosis. Thus, the D6 decoy receptor plays a key role in setting the balance between antimicrobial resistance, immune activation, and inflammation in M. tuberculosis infection.
###end p 3
###begin p 4
Abbreviations used: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BAL, bronchoalveolar lavage; BCG, bacille Calmette-Guerin; BUN, blood urea nitrogen; i.n., intranasal; MCP, monocyte chemotactic protein; MIP, macrophage inflammatory protein; RANTES, regulated on activation, normal T cell expressed and secreted.
###end p 4
###begin p 5
D. Di Liberto and M. Locati contributed equally to this paper.
###end p 5
###begin p 6
###xml 221 222 221 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 279 280 275 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 282 283 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 551 552 547 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 682 683 678 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 943 944 939 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 1158 1159 1154 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 1660 1661 1656 1657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 1775 1776 1771 1772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 1778 1779 1774 1775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 1972 1973 1968 1969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
The formation of granulomas at the site of mycobacterial infection is an essential component of host immunity for controlling infection. This process is dependent on the activation of mycobacteria-reactive T lymphocytes (1), particularly IFN-gamma-secreting CD4 and CD8 T cells (2, 3). Granuloma formation, however, is a complex process that requires not only the activation of lymphocytes, but also their recruitment with monocytes to the site of the infection, migration into the tissues, and juxtaposition around mycobacteria-infected macrophages (4). This colocalization facilitates the activation of bactericidal mechanisms in infected macrophages by T cell-derived cytokines (1). Some mycobacteria, however, survive within macrophages, and persistent antigenic stimulation perpetuates the process, leading to chronic granuloma formation characterized by dense accumulations of infected macrophages, epithelioid cells, and T lymphocytes (5). These granulomas contain the mycobacterial infection and prevent dissemination to other organs, but they are also responsible for lung immunopathology, as the granulomas displace and destroy parenchymal tissue (6). One of the major roles of the granuloma is to localize and contain not only the bacteria but also the inflammatory response to the bacteria itself. Indeed, if immune cells are not tightly controlled within the lungs, this could lead to excess inflammation. Thus, rigorous control of the organization of granulomas is likely necessary to prevent immunopathology. In most cases, after the repair of an inflamed or damaged tissue, inflammation subsides and the tissue returns to its homeostatic norm (7). However, if the resolution phase of inflammation is ineffective, chronic inflammatory pathologies may develop (7, 8). Failure to resolve ongoing inflammation is an invariable key feature of pathologies, which are typically characterized by the high-level expression of inflammatory cytokines and chemokines (9). Therefore, understanding the resolution phase of transient inflammatory responses will probably yield insights into some of these chronic inflammatory pathologies.
###end p 6
###begin p 7
###xml 54 56 46 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 57 59 49 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 251 277 243 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 302 304 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 305 307 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 360 375 348 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 627 629 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 952 967 936 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 1004 1006 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 251 277 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 360 375 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 952 967 <span type="species:ncbi:1773">M. tuberculosis</span>
TNF-alpha and the related cytokine lymphotoxin-alpha (10-13) are potent proinflammatory cytokines with a wide range of activities in both the inflammatory and immune responses, and they play an essential role in host resistance against infection with Mycobacterium tuberculosis and other mycobacteria (10-12). TNF-alpha-deficient mice infected by aerosol with M. tuberculosis develop normal T cell responses to mycobacterial antigens, but because of the failure of granuloma formation in the infected organs they are profoundly susceptible to the infection, succumbing with extensive necrosis in the lungs and infected organs (12). Other than TNF-alpha, the role of other soluble mediators in regulating granuloma formation and persistence is poorly understood. Chemokines and their receptors are involved in cell migration and are logical candidates for a role in granuloma formation, although their expression has been studied to a limited degree in M. tuberculosis infection (for review see reference 14). In general, the production of chemokines at a certain level may be a factor in preventing cell movement out of the granuloma.
###end p 7
###begin p 8
###xml 73 74 73 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 1282 1283 1282 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 1285 1287 1285 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 1414 1417 1414 1417 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1508 1510 1508 1510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 1570 1572 1570 1572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 1597 1600 1597 1600 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2032 2047 2032 2047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 2063 2066 2063 2066 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1418 1422 <span type="species:ncbi:10090">mice</span>
###xml 1601 1605 <span type="species:ncbi:10090">mice</span>
###xml 2032 2047 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 2067 2071 <span type="species:ncbi:10090">mice</span>
Recently, studies of the D6 chemokine receptor (for review see reference 9) have provided novel insights regarding the mechanism of chemokine removal from inflamed sites. D6 is structurally similar to the other chemokine receptors, and is most homologous to CCR4 and CCR5. However, several properties set D6 apart from other CCRs. First, D6 is extremely promiscuous, recognizing 15 chemokines. Interestingly, all D6 ligands are inflammatory CC chemokines, whereas constitutive CC chemokines, as well as chemokines of other subfamilies, are not recognized. Thus, D6 is a promiscuous receptor with selectivity for inflammatory CC chemokines. Second, the D6 expression pattern is unusual, with the predominant expression sites being trophoblasts in the placenta and lymphatic endothelial cells in the skin, gut, and lung. Third, and most crucially, D6 does not signal in response to the binding of any of its ligands. Conversely, the only apparent function of D6 is to convey the entire ligand-receptor complex intracellularly, target the chemokine for degradation, and recycle the receptor to the membrane. This observation, together with the ability of D6 to bind most inflammatory CC chemokines, has resulted in the proposal that D6 functions as a "scavenging" or "decoy" receptor (9, 15), and has suggested a role for D6 in controlling the resolution of CC chemokine-driven inflammatory responses. Accordingly, D6-/- mice display exaggerated inflammatory responses after skin application of phorbol esters (15) and subcutaneous injection of complete Freund's adjuvant (16). In this last model, D6-/- mice developed granulomas characterized by angiogenesis, extensive leukocyte infiltration, and prominent areas of necrosis more rapidly and severely than WT counterparts. However, whether D6 plays a similar role in inflammatory responses caused by infectious microorganisms, or has a role in the induction of a protective response to infectious agents, is presently unknown. To test this possibility, we have studied the course of M. tuberculosis infection in D6-/- mice.
###end p 8
###begin title 9
RESULTS
###end title 9
###begin title 10
###xml 37 52 37 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 37 52 <span type="species:ncbi:1773">M. tuberculosis</span>
Expression of the D6 receptor during M. tuberculosis infection
###end title 10
###begin p 11
###xml 72 87 72 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 486 501 486 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 628 630 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 692 707 692 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 72 87 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 102 107 <span type="species:ncbi:9606">human</span>
###xml 137 144 <span type="species:ncbi:9606">patient</span>
###xml 311 316 <span type="species:ncbi:10090">mouse</span>
###xml 486 501 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 692 707 <span type="species:ncbi:1773">M. tuberculosis</span>
Preliminarily, we investigated the expression of the D6 receptor during M. tuberculosis infection. In human lungs and lymph nodes from a patient with pulmonary tuberculosis, D6 expression was observed in lymphatic endothelial cells and only occasionally in scattered leukocytes (Fig. S1, available at ). In the mouse, qualitative RT-PCR experiments indicated that D6 transcripts in the liver, spleen, and lungs do not undergo significant changes at 4, 8, and 12 wk after infection with M. tuberculosis (Fig. S2). These data suggest that D6 is mainly expressed in lymphatic endothelial cells, in agreement with previous reports (17), and that its expression does not change appreciably during M. tuberculosis infection.
###end p 11
###begin title 12
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 31 34 31 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
M. tuberculosis infection in D6-/- mice
###end title 12
###begin p 13
###xml 68 83 68 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 104 107 104 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 239 247 239 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 259 274 259 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 290 293 290 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 506 514 494 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 536 539 524 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 726 729 714 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 738 753 726 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 938 946 926 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 68 83 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 259 274 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 294 298 <span type="species:ncbi:10090">mice</span>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 666 670 <span type="species:ncbi:10090">mice</span>
###xml 730 734 <span type="species:ncbi:10090">mice</span>
###xml 738 753 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 815 819 <span type="species:ncbi:10090">mice</span>
To determine whether the D6 receptor plays a role in the control of M. tuberculosis infection, WT and D6-/- mice were infected via the intranasal (i.n.) route with 2,000 CFU. This dose did not cause mortality in C57BL/6 mice in our study (Fig. 1 A). However, M. tuberculosis infection in D6-/- mice resulted in increased mortality, with approximately20% of mice succumbing by week 8, 50% of mice succumbing by week 12, and 100% of mice succumbing at week 16, at which time the experiments were terminated (Fig. 1 A). The phenotype of D6-/- was dramatic and was found highly reproducible over a period of 3 yr in two additional experiments performed on a total of 17 mice per group. Despite the exaggerated susceptibility of D6-/- mice to M. tuberculosis infection, there was no difference between the two groups of mice in bacterial loads, as determined by CFU counts in the lung, liver, and spleen at 2, 4, 8, and 12 wk after infection (Fig. 1 B).
###end p 13
###begin p 14
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 31 34 31 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 40 0 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>M. tuberculosis</italic> infection in D6<sup>&#8722;/&#8722;</sup> mice.</bold>
###xml 89 92 89 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 138 139 138 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 144 159 144 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 161 162 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 277 280 277 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 347 362 347 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 402 405 402 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 451 452 451 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 457 472 457 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 610 613 608 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 717 720 715 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 756 771 754 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 1127 1130 1124 1127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1167 1170 1164 1167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 144 159 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 347 362 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
###xml 457 472 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
###xml 721 725 <span type="species:ncbi:10090">mice</span>
###xml 756 771 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1108 1112 <span type="species:ncbi:10090">mice</span>
###xml 1131 1135 <span type="species:ncbi:10090">mice</span>
###xml 1171 1175 <span type="species:ncbi:10090">mice</span>
M. tuberculosis infection in D6-/- mice. (A) Survival curve of WT (closed squares) and D6-/- (open squares) mice infected i.n. with 2 x 103 CFU M. tuberculosis (n = 10). Data indicate the percentage of surviving mice over time. The difference in the survival rates of WT and D6-/- mice was statistically significant (P < 0.001). (B) The course of M. tuberculosis infection in WT (closed squares) and D6-/- (open squares) mice infected i.n. with 2 x 103 CFU M. tuberculosis and followed against time in the lungs, liver, and spleen. Data shown are the mean bacterial counts +/- SD. Differences between WT and D6-/- mice were not statistically significant at any time point. (C) Liver and kidney sections from WT and D6-/- mice at 12 wk after infection with M. tuberculosis. Hematoxylin and eosin staining is shown. Bars, 250 mum. Insets show magnified structures. Original magnification was 100x for the main images and 400x for the insets. (D) Transaminase (ALT and AST) levels are shown. (E) BUN and proteinuria values are shown. Similar results were obtained in five different experiments (shaded bars, WT mice; open bars, D6-/- mice). Differences between WT and D6-/- mice were highly statistically significant (P < 0.001). Data are the mean +/- the SD.
###end p 14
###begin p 15
###xml 43 58 43 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 220 228 220 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 535 538 535 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 549 557 549 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 624 627 624 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 661 669 661 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 728 743 728 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 806 809 806 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 833 841 833 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 935 943 935 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 987 1002 987 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 1063 1066 1063 1066 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1199 1207 1199 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 E</xref>
###xml 1228 1243 1228 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 1274 1282 1274 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 1305 1320 1305 1320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 1353 1356 1353 1356 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 43 58 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 628 632 <span type="species:ncbi:10090">mice</span>
###xml 655 659 <span type="species:ncbi:10090">mice</span>
###xml 728 743 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 827 831 <span type="species:ncbi:10090">mice</span>
###xml 987 1002 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1067 1071 <span type="species:ncbi:10090">mice</span>
###xml 1193 1197 <span type="species:ncbi:10090">mice</span>
###xml 1228 1243 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1305 1320 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1357 1361 <span type="species:ncbi:10090">mice</span>
Of note, CFU data at 4, 8, and 12 wk after M. tuberculosis infection were rechecked in two additional independent experiments with three mice per group performed over a period of 2 yr, confirming the results reported in Fig. 1 B. We then examined by histology the effect of D6 deficiency on the inflammatory response in the lungs, liver, and spleen. Although in WT mice a moderate cellular infiltration was seen at 12 wk after infection and most of the lung airspace remained intact, an exaggerated response was evident in surviving D6-/- mice (see Fig. 5 A). Histological analysis also showed a diffuse liver necrosis in D6-/- mice when compared with WT mice (Fig. 1 C). In agreement with the histology results, at 12 wk after M. tuberculosis infection, serum transaminases were abnormally increased in D6-/- compared with WT mice (Fig. 1 D). Areas of focal necrosis and mononuclear cell infiltrates were also evident in the kidneys (Fig. 1 C), and consistent with this, at 12 wk after M. tuberculosis infection renal function was also severely compromised in D6-/- mice, which had significantly higher blood urea nitrogen (BUN) levels and frequency of severe proteinuria as compared with WT mice (Fig. 1 E). Of note, although M. tuberculosis growth occurred in the liver (Fig. 1 B), we failed to detect M. tuberculosis CFU in kidneys of both WT and D6-/- mice over a 12-wk period (not depicted). Thus, despite the successful control of the growth of the infecting mycobacteria, D6 deficiency led to increased mortality associated with lung inflammation and combined renal and liver failure.
###end p 15
###begin title 16
###xml 41 56 41 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 41 56 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Leukocyte infiltration in tissues during M. tuberculosis infection in D6-/- mice
###end title 16
###begin p 17
###xml 64 67 64 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 79 94 79 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 273 279 273 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 303 304 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 314 315 314 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 331 339 331 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 384 387 384 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 487 490 487 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 599 614 599 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 626 629 626 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 700 704 700 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 710 714 710 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 725 728 725 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 989 992 989 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1101 1109 1101 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 79 94 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
###xml 491 495 <span type="species:ncbi:10090">mice</span>
###xml 599 614 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
###xml 822 826 <span type="species:ncbi:10090">mice</span>
###xml 1000 1004 <span type="species:ncbi:10090">mice</span>
We examined the cellular infiltrate in the lungs and liver of D6-/- mice after M. tuberculosis infection. At predetermined time points, organs were removed, the total number of cells was calculated, and flow cytometric analysis was performed to determine cell populations (Fig. 2). Numbers of DCs (F4/80- and CD11c+) in the lungs (Fig. 2 A) were not significantly different between D6-/- and WT mice. The numbers of macrophages and CD4 and CD8 lymphocytes were significantly higher in D6-/- mice at all time points after infection. Approximately 45% of CD4 and CD8 T cells infiltrating the lungs of M. tuberculosis-infected D6-/- mice at 8 and 12 wk after infection expressed activation markers (CD25high, CD44high, and CD62Llow), whereas only 30% of CD4 and 35% of CD8 T cells expressed the same activation markers in WT mice, although differences were not statistically significant (unpublished data). Similar findings were also detected in the liver, although the differences between D6-/- and WT mice were lower than in the lungs and generally reached significance at 8 and 12 wk after infection (Fig. 2 B).
###end p 17
###begin p 18
###xml 70 85 70 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Leukocyte recruitment to tissues and lymph nodes after infection with <italic>M. tuberculosis</italic>.</bold>
###xml 205 208 205 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 300 315 300 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 70 85 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 300 315 <span type="species:ncbi:1773">M. tuberculosis</span>
Leukocyte recruitment to tissues and lymph nodes after infection with M. tuberculosis. Leukocytes were isolated from the lungs (A), livers (B), and mediastinal lymph nodes (C) of WT (closed squares) and D6-/- (open squares) mice and analyzed by flow cytometry at different times after infection with M. tuberculosis. The cells were stained with fluorescent antibodies to F4/80 (macrophages), CD11c (bright; DCs), CD4, and CD8. Shown are the mean cell numbers +/- SD for each cell type. Similar results were obtained in five different experiments. *, P < 0.001; **, P < 0.01.
###end p 18
###begin title 19
Cell migration to lymph nodes
###end title 19
###begin p 20
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 334 337 334 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 356 371 356 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 395 403 395 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 485 488 485 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 666 669 666 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 767 770 767 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1196 1199 1196 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1301 1307 1297 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 356 371 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
###xml 670 674 <span type="species:ncbi:10090">mice</span>
###xml 771 775 <span type="species:ncbi:10090">mice</span>
###xml 1200 1204 <span type="species:ncbi:10090">mice</span>
Because of the finding that the lungs of D6-/- mice contained more macrophages and T lymphocytes than the lungs of WT mice, we asked whether a greater number of these cells migrated from the lungs to the draining lymph nodes. To investigate this possibility, flow cytometric analysis was performed on the mediastinal lymph nodes of D6-/- and WT mice after M. tuberculosis infection. As shown in Fig. 2 C, the number of macrophages showed a significant increase in the lymph nodes of D6-/- mice at 4 wk after infection. At 4 and 8 but not 12 wk after infection, there were also statistically significant differences in the total number of DCs in the lymph nodes of D6-/- mice. The numbers of CD4 and CD8 T lymphocytes were significantly higher in the lymph nodes of D6-/- mice at 4 and 8 wk after infection, but although the latter constantly increased, the former peaked at week 4 and then decreased. The increased migration of DCs and T lymphocytes to the lymph nodes was expected to result in increased numbers of primed T lymphocytes, followed by migration to the lungs. ELISPOT analysis confirmed this hypothesis, showing that significantly more CD4 and CD8 T lymphocytes from the lungs of D6-/- mice were primed to produce IFN-gamma when stimulated by bacille Calmette-Guerin (BCG)-infected DCs (Fig. 3).
###end p 20
###begin p 21
###xml 74 89 70 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 0 90 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IFN-&#947;&#8211;producing CD4 and CD8 T cells in the lungs after infection with <italic>M. tuberculosis</italic>.</bold>
###xml 152 155 148 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 502 505 482 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 74 89 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 506 510 <span type="species:ncbi:10090">mice</span>
IFN-gamma-producing CD4 and CD8 T cells in the lungs after infection with M. tuberculosis. Lung leukocytes were isolated from WT (closed squares) and D6-/- (open squares) mice at the indicated time points after infection and were restimulated in vitro with irradiated BCG-infected WT DCs for 36-40 h at 37degreesC. The numbers of IFN-gamma-producing CD4 and CD8 T cells were quantified by ELISPOT at the indicated weeks. The mean numbers +/- SD of IFN-gamma-producing CD4 and CD8 T cells from WT and D6-/- mice at each time point are shown. Similar results were obtained in five different experiments. *, P < 0.005; **, P < 0.01.
###end p 21
###begin title 22
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
Chemokine and cytokine levels in D6-/- mice
###end title 22
###begin p 23
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 260 275 260 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 303 311 303 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 399 402 399 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 725 728 714 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 760 768 749 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 782 797 771 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 1195 1197 1172 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 1199 1201 1176 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 1203 1205 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 1363 1378 1340 1355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 1535 1543 1501 1509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 1556 1564 1522 1530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 1569 1584 1535 1550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 1596 1599 1562 1565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1673 1688 1639 1654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 260 275 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 729 733 <span type="species:ncbi:10090">mice</span>
###xml 782 797 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1363 1378 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1388 1392 <span type="species:ncbi:10090">mice</span>
###xml 1569 1584 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1600 1604 <span type="species:ncbi:10090">mice</span>
###xml 1661 1665 <span type="species:ncbi:10090">mice</span>
###xml 1673 1688 <span type="species:ncbi:1773">M. tuberculosis</span>
Previous studies have shown that exacerbated inflammation in mice lacking the D6 receptor is associated with higher levels of chemokines in blood and tissues (15, 16, 18). We therefore examined chemokine levels in the bronchoalveolar lavage (BAL) and serum of M. tuberculosis-infected mice. As shown in Fig. 4 A, the concentrations of all tested chemokines were significantly higher in the BAL of D6-/- than of WT mice at 12 wk after infection. Similarly, concentrations of CCL2/monocyte chemotactic protein 1 (MCP-1), CCL3/macrophage inflammatory protein 1alpha (MIP-1alpha), CCL4/MIP-1beta, and CCL5/regulated on activation, normal T cell expressed and secreted (RANTES) were also significantly increased in the serum of D6-/- mice at 12 wk after infection (Fig. 4 B). Control of M. tuberculosis infection depends on the activation of macrophages by IFN-gamma and TNF-alpha, leading to the induction of inducible NO synthase and the production of reactive nitrogen intermediates such as NO. TNF-alpha is reported to be essential for the early expression of mRNA encoding CC and CXC chemokines, the initial recruitment of CD4 T lymphocytes, and the formation and maintenance of the granulomas (12, 19, 20). To determine whether these components of the antimycobacterial immune response were affected by D6 deficiency, ELISA was performed on the BAL and serum of M. tuberculosis-infected mice at 8 (unpublished data) and 12 wk after infection. Concentrations of TNF-alpha, IL-1beta, and IFN-gamma were significantly higher in the BAL (Fig. 4 C) and serum (Fig. 4 D) of M. tuberculosis-infected D6-/- mice at all tested time points, as compared with infected WT mice. Thus, M. tuberculosis infection in the presence of D6 deficiency causes a local and systemic inflammatory response characterized by increased levels of proinflammatory chemokines and cytokines.
###end p 23
###begin p 24
###xml 54 69 54 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 88 91 88 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 97 0 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Chemokine and cytokine levels in the BAL and serum of <italic>M. tuberculosis</italic>&#8211;infected WT and D6<sup>&#8722;/&#8722;</sup> mice.</bold>
###xml 121 124 121 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 166 181 166 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 54 69 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 166 181 <span type="species:ncbi:1773">M. tuberculosis</span>
Chemokine and cytokine levels in the BAL and serum of M. tuberculosis-infected WT and D6-/- mice. WT (shaded bars) and D6-/- (open bars) mice were infected i.n. with M. tuberculosis, and BAL or sera were obtained 12 wk later. The levels of CC chemokines (A and B) and cytokines (C and D) were measured by ELISA. Shown are the mean values +/- SD. Similar results were obtained in three different experiments. *, P < 0.001; **, P < 0.01.
###end p 24
###begin title 25
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Neutralization of chemokines in D6-/- mice in vivo reverses pathology but increases susceptibility to infection
###end title 25
###begin p 26
###xml 56 71 56 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 329 332 329 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 601 603 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 605 607 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 796 811 789 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 984 987 970 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1147 1150 1133 1136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1247 1250 1233 1236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1776 1779 1751 1754 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1924 1939 1899 1914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 1941 1948 1916 1923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table I</xref>
###xml 2062 2070 2037 2045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 2090 2093 2065 2068 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2147 2162 2122 2137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 2235 2243 2210 2218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 2323 2338 2298 2313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 56 71 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
###xml 685 689 <span type="species:ncbi:10090">mice</span>
###xml 765 769 <span type="species:ncbi:10090">Mice</span>
###xml 796 811 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 988 992 <span type="species:ncbi:10090">mice</span>
###xml 1078 1082 <span type="species:ncbi:10090">mice</span>
###xml 1151 1155 <span type="species:ncbi:10090">mice</span>
###xml 1251 1255 <span type="species:ncbi:10090">mice</span>
###xml 1674 1678 <span type="species:ncbi:10090">mice</span>
###xml 1780 1784 <span type="species:ncbi:10090">mice</span>
###xml 1924 1939 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 2094 2098 <span type="species:ncbi:10090">mice</span>
###xml 2147 2162 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 2323 2338 <span type="species:ncbi:1773">M. tuberculosis</span>
The results in the previous paragraph clearly show that M. tuberculosis infection in the absence of the D6 receptor is characterized by an exaggerated inflammatory response and increased mortality, despite the successful control of bacterial growth. To investigate whether the highly increased levels of chemokines observed in D6-/- mice were involved in the pathogenesis, we attempted to block inflammatory chemokines in vivo. For this purpose, mice were treated with a mixture of antibodies to the CC chemokines CCL2/MCP-1, CCL3/MIP-1alpha, CCL4/MIP-1beta, and CCL5/RANTES, as previously described (15, 18), or with antibodies to each individual chemokine. On the same days, control mice received i.p. injections of an equivalent amount of irrelevant antibodies. Mice were injected weekly with M. tuberculosis, starting from the third week after infection. Following this treatment schedule, CCL2/MCP-1, CCL3/MIP-1alpha, CCL4/MIP-1beta, and CCL5/RANTES production in the serum of D6-/- mice was consistently reduced (Table S1, available at ), even below levels detected in WT mice, thus demonstrating the efficacy of the blocking. Conversely, D6-/- mice treated with control antibody had very high levels of serum chemokines, as did untreated D6-/- mice. TNF-alpha, IL-1beta, and IFN-gamma levels in serum were also consistently reduced by treatment with antibodies to CC chemokines (Table S1), and cellular influx to the infected tissues significantly decreased (unpublished data). Additionally, both renal and liver function appeared improved by this treatment, as suggested by the low levels of serum transaminases and BUN, and by the low proteinuria detected in these mice (Table S1). Overall, the most impressive consequence of the neutralization of CC chemokines in D6-/- mice was a significantly prolonged survival, as demonstrated by the only 10% mortality at 12 wk and 30% mortality at 16 wk after infection with M. tuberculosis (Table I). However, in spite of the ability of chemokine-blocking antibodies to reduce the overall inflammatory response (Fig. 5 A), the ability of D6-/- mice treated in this manner to control the growth of M. tuberculosis in the lungs was impaired, with higher CFU counts found at 8 and 12 wk (Fig. 5 B). This result therefore indicates that the D6 receptor plays a crucial role in M. tuberculosis infection, and in the balance between immunopathology and protective immune responses.
###end p 26
###begin p 27
###xml 76 79 76 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 88 103 88 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 88 103 <span type="species:ncbi:1773">M. tuberculosis</span>
Effects of treatment with anti-CC chemokine antibodies on the survival of D6-/- mice to M. tuberculosis infection
###end p 27
###begin p 28
###xml 14 17 14 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 223 238 223 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 353 354 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 434 437 434 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 3 7 <span type="species:ncbi:10090">mice</span>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 223 238 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 240 244 <span type="species:ncbi:10090">Mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
WT mice and D6-/- mice either untreated or treated with monoclonal antibodies to single individual CC chemokines, or with a cocktail of anti-CC chemokines (mix antibody) or irrelevant control antibodies, were infected with M. tuberculosis. Mice were scored for survival over time. Data shown are the numbers of deaths out of the number of treated mice (n = 10 per group). *, P < 0.001; and **, P < 0.01 when compared with values in D6-/- mice either untreated (Nil) or treated with control antibody.
###end p 28
###begin p 29
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 28 31 28 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 79 0 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>M. tuberculosis</italic> growth in D6<sup>&#8722;/&#8722;</sup> mice treated with anti&#8211;CC chemokine antibodies.</bold>
###xml 98 101 98 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 258 273 258 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 318 333 318 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 628 643 626 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 700 703 698 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 909 924 907 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 1022 1025 1018 1021 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 258 273 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 318 333 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 399 404 <span type="species:ncbi:10090">mouse</span>
###xml 628 643 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 689 693 <span type="species:ncbi:10090">mice</span>
###xml 704 708 <span type="species:ncbi:10090">mice</span>
###xml 909 924 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1026 1030 <span type="species:ncbi:10090">mice</span>
M. tuberculosis growth in D6-/- mice treated with anti-CC chemokine antibodies. (A) WT mice and D6-/- mice either untreated (Nil), or treated with a cocktail of anti-CC chemokine (Anti-CC Ab) or irrelevant control antibodies (Control Ab), were infected with M. tuberculosis. Granulomatous infiltration in the lungs of M. tuberculosis-infected mice was assessed by analyzing two lung lobes from each mouse. Data are expressed as the percentage +/- SD of the lung area involved, calculated by dividing the granuloma-involved area by the total tissue area. A representative of two different experiments is shown. (B) The course of M. tuberculosis infection followed against time in lungs. WT mice and D6-/- mice either untreated (Nil), or treated with antibodies against individual chemokines, with a cocktail of anti-CC chemokine (Mix Ab), or with irrelevant control antibodies (Control Ab), were infected with M. tuberculosis. Data shown are the mean bacterial counts +/- SD. *, P < 0.01 when compared with CFU values in D6-/- mice either untreated (Nil) or treated with control antibody.
###end p 29
###begin title 30
DISCUSSION
###end title 30
###begin p 31
###xml 241 256 241 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 401 403 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 789 804 781 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 976 991 968 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 993 995 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 1037 1052 1029 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 1529 1544 1505 1520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 1795 1797 1763 1765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 241 256 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 789 804 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 976 991 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1037 1052 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1086 1091 <span type="species:ncbi:10090">mouse</span>
###xml 1529 1544 <span type="species:ncbi:1773">M. tuberculosis</span>
A better understanding of the immunological mechanisms of pathogenesis and protection is of essential importance for the design of novel vaccines and immunotherapies against tuberculosis. It has been proposed that the protective response to M. tuberculosis infection requires CD4 and CD8 lymphocytes, the Th1-type cytokines IFN-gamma and TNF-alpha, and activated macrophages (for review see reference 21). The cooperation between the cells and cytokines requires close interaction, which is achieved after migration and granuloma formation in the lungs. The hallmark of infection in the lung is granuloma formation, consisting of clusters of macrophages, lymphocytes, and DCs, which physically contains the mycobacteria and creates a microenvironment for immune cell interaction, limiting M. tuberculosis growth and dissemination. Chemokines are potent leukocyte activators and chemoattractants aiding granuloma formation and thought to be critical for the immune response to M. tuberculosis (14). In vitro experiments demonstrated that M. tuberculosis infection of bone marrow-derived mouse macrophages results in the expression of TNF-alpha, as well as several chemokines, including ligands for the chemokine receptors CXCR3, CCR5, and CCR2. Neutralization of TNF-alpha by using antibody or TNFR1-deficient macrophages demonstrated that expression of certain chemokines (CXCL9/monokine induced by IFN-gamma, CXCL10/IFN-inducible protein 10, CXCL11/IFN-inducible T cell alpha chemoattractant, CCL5/RANTES, and CCL2/MCP-1) after M. tuberculosis infection was dependent, at least in part, on TNF-alpha. However, the lack of TNF-alpha did not completely abrogate chemokine expression, indicating that there are other factors, induced as a result of infection, that stimulate chemokine production (22).
###end p 31
###begin p 32
###xml 95 110 95 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 222 237 222 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 396 411 396 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 569 584 569 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 673 688 673 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 887 889 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 3 8 <span type="species:ncbi:10090">mouse</span>
###xml 95 110 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 222 237 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 396 411 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 569 584 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
###xml 673 688 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 765 769 <span type="species:ncbi:10090">mice</span>
###xml 806 821 <span type="species:ncbi:10090">transgenic mice</span>
In mouse models, gene expression of CXC and CC chemokines has been detected in the lungs after M. tuberculosis infection (22-24). CXCR3-deficient mice (25) have an impaired granuloma formation after aerosol infection with M. tuberculosis, although this effect is transient, occurring at the early stages of infection. CCR2-deficient mice are extraordinarily susceptible to moderate- or high-dose M. tuberculosis administered i.v. (26), and susceptibility is dose-dependent (27). Conversely, CCR5 (28) may not be essential to the development of a protective response to M. tuberculosis infection. CCL2/MCP-1-deficient mice did not demonstrate an increased susceptibility to M. tuberculosis infection, but whether cell infiltration or histology was affected in these mice was not reported (29, 30). However, transgenic mice overexpressing CCL2/MCP-1 were more susceptible to tuberculosis (31).
###end p 32
###begin p 33
###xml 67 68 67 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 469 484 469 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 544 547 544 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 705 720 705 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 876 891 876 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 920 923 920 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1110 1125 1110 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 1257 1260 1257 1260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1639 1654 1628 1643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 1687 1690 1676 1679 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1743 1758 1732 1747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 2191 2194 2180 2183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2205 2220 2194 2209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 2343 2346 2332 2335 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2450 2453 2435 2438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2614 2617 2599 2602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2779 2781 2764 2766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 2802 2804 2787 2789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 2809 2812 2794 2797 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 3030 3033 3015 3018 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 3134 3149 3119 3134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 3161 3164 3146 3149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 3867 3882 3845 3860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 3894 3897 3872 3875 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 3969 3972 3947 3950 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 4278 4281 4249 4252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 4394 4409 4365 4380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 4514 4521 4485 4492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table I</xref>
###xml 454 459 <span type="species:ncbi:10090">mouse</span>
###xml 469 484 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
###xml 705 720 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 729 733 <span type="species:ncbi:10090">mice</span>
###xml 762 766 <span type="species:ncbi:10090">mice</span>
###xml 801 805 <span type="species:ncbi:10090">mice</span>
###xml 876 891 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1050 1054 <span type="species:ncbi:10090">mice</span>
###xml 1110 1125 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1261 1265 <span type="species:ncbi:10090">mice</span>
###xml 1639 1654 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1691 1695 <span type="species:ncbi:10090">mice</span>
###xml 1743 1758 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 2194 2198 <span type="species:ncbi:10090">mice</span>
###xml 2205 2220 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 2347 2351 <span type="species:ncbi:10090">mice</span>
###xml 2454 2458 <span type="species:ncbi:10090">mice</span>
###xml 2618 2622 <span type="species:ncbi:10090">mice</span>
###xml 2813 2817 <span type="species:ncbi:10090">mice</span>
###xml 3034 3038 <span type="species:ncbi:10090">mice</span>
###xml 3134 3149 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 3165 3169 <span type="species:ncbi:10090">mice</span>
###xml 3867 3882 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 3898 3902 <span type="species:ncbi:10090">mice</span>
###xml 3973 3977 <span type="species:ncbi:10090">mice</span>
###xml 4282 4286 <span type="species:ncbi:10090">mice</span>
###xml 4347 4351 <span type="species:ncbi:10090">mice</span>
###xml 4394 4409 <span type="species:ncbi:1773">M. tuberculosis</span>
The action of chemokines is tightly controlled by decoy receptors (9), which internalize and target chemokines for intracellular degradation, thus avoiding excessive inflammatory responses and the consequent tissue damage. D6 is a decoy receptor that recognizes most inflammatory CC chemokines, implying that it may play a key role in resolving CC chemokine-driven inflammatory responses. The results reported in this paper confirm this possibility in a mouse model of M. tuberculosis infection through the mucosal (i.n.) route and show that D6-/- mice have an exaggerated inflammatory response leading to death, despite their ability to efficiently control bacterial load. Upon i.n. delivery of low-dose M. tuberculosis, 20% of mice succumbed at week 8, 50% of mice succumbed at week 12, and 100% of mice succumbed at week 16, despite the successful control of the growth of M. tuberculosis bacilli. The phenotype of D6-/- was dramatic and was found highly reproducible over a period of 3 yr in two additional experiments performed on a total of 17 mice per group. Moreover, CFU data at 4, 8, and 12 wk after M. tuberculosis infection were found highly reproducible in two additional independent experiments performed over a period of 2 yr. Mortality in D6-/- mice coincided with an overwhelming local and systemic inflammatory response that mainly compromised liver and kidney functions in the host, characterized by increased and sustained numbers of macrophages, DCs, and CD4 and CD8 T lymphocytes, and increased production of inflammatory CC chemokines and cytokines (TNF-alpha, IL-1beta, and IFN-gamma). However, we failed to detect M. tuberculosis CFU in kidneys of both WT and D6-/- mice over a 12-wk period. This might reflect either M. tuberculosis growth below the CFU detection limit or the development of kidney damage in the absence of kidney infection. A similar increase in macrophage, DC, and T cell numbers was detected in the mediastinal lymph nodes, suggesting the possibility that more T lymphocytes were being primed and migrating to the lungs. Such increased priming likely accounts for the substantially increased numbers of T lymphocytes migrating to the lungs of D6-/-mice after M. tuberculosis infection, as confirmed by ELISPOT analysis showing that significantly more CD4 and CD8 T lymphocytes from the lungs of D6-/- mice were primed to produce IFN-gamma when stimulated in vitro by BCG-infected DCs. The finding that D6-/- mice had more inflammation is intriguing and convincingly supports an immunoregulatory role for the D6 receptor. Recent data in other systems have shown that D6-/- mice display exaggerated responses to inflammatory stimuli, resulting in an aggressive cutaneous inflammatory pathology after the application of phorbol esters (15). In another study (16), D6-/- mice displayed an exaggerated response to the subcutaneous injection of complete Freund's adjuvant. Unfortunately, none of these studies has been able to define a mechanism for the heightened immune response in the D6-/- mice. Although there are several different possibilities for the increased inflammatory response in M. tuberculosis-infected D6-/- mice, the one we favor is that lack of the D6 receptor fails to remove CC chemokines from many different organs and tissues, determining their increased concentration. Such increased expression/circulation of CC chemokines may, in turn, lead to signaling through their receptors and could result in the influx of immune cells and abundant, uncontrolled production of proinflammatory cytokines, which ultimately mediate tissue damage. However, the increased expression may also have been a reaction to the numbers of cells in infected organs. Whatever the case, the concentrations of CCL2/MCP-1, CCL3/MIP-1alpha, CCL4/MIP-1beta, and CCL5/RANTES were found to be highly increased in the BAL and serum of M. tuberculosis-infected D6-/- mice and sustained over time; moreover, blocking all four of them in D6-/- mice in vivo (CCL2/MCP-1, CCL3/MIP-1alpha, CCL4/MIP-1beta, and CCL5/RANTES) by repeated injection of a cocktail of neutralizing antibodies significantly reduced cell recruitment, production of proinflammatory CC chemokines and cytokines, liver and kidney damage, and, most importantly, the mortality of D6-/- mice. However, despite controlling inflammatory responses, these mice became more susceptible to infection with M. tuberculosis, as demonstrated by higher CFU counts in the lungs at 8 and 12 wk after infection. The data reported in Table I clearly show that none of the neutralized chemokines alone accounts for the reduced inflammatory response and mortality, and for the increased susceptibility to infection.
###end p 33
###begin p 34
###xml 161 164 154 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 262 264 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 266 268 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 349 364 342 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 376 378 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 474 476 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 557 572 550 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 621 623 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 706 721 699 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 733 735 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 1432 1447 1414 1429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 349 364 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
###xml 557 572 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
###xml 706 721 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1432 1447 <span type="species:ncbi:1773">M. tuberculosis</span>
CCL3/MIP-1alpha, CCL4/MIP-1beta, and CCL5/RANTES are all ligands of CCR5, which can attract and activate macrophages and Th1 lymphocytes. However studies in CCR5-/- mice have found that although CCR5 plays a role in the migration of DCs to and from lymph nodes (28, 32), it is not indispensable for granuloma formation and immune protection against M. tuberculosis infection (32). CCL5/RANTES has been associated with the generation of type 1 cytokine-producing granulomas (33). CCR2-deficient mice are extraordinarily susceptible to moderate- or high-dose M. tuberculosis administered i.v. but not to low aerosol doses (27), and CCL2/MCP-1-deficient mice do not demonstrate an increased susceptibility to M. tuberculosis infection (29). However, there is redundancy in the chemokine system. Specific to this study, the chemokines CCL2/MCP-1, CCL3/MIP-1alpha, CCL4/MIP-1beta, and CCL5/RANTES are ligands of CCR5, but CCL3/MIP-1alpha and CCL5/RANTES can also signal through CCR1 and CCR3. This finding makes it difficult to dissect the precise roles of individual chemokines and their receptors. In this study, enhancing the type 1 T cell response or the ability of T lymphocytes to enter the lungs over the WT level does not have an obvious beneficial effect on the control of infection and inflammation, indicating that there are additional factors that must be induced or enhanced to increase the ability of the host to eliminate M. tuberculosis infection.
###end p 34
###begin p 35
In summary, our study suggests an important role for the D6 receptor in immune regulation. D6 controls chemokine accumulation and activity, migration, and possibly, the maintenance of DCs and T cells in infected organs, as well as the production of inflammatory cytokines. Therefore D6, through its ability to avoid an excess of chemokines in the inflamed tissue, may favor resolution of chronic inflammatory responses and overall provide a fine mechanism for the control of the balance between protective immune responses and immunopathology.
###end p 35
###begin title 36
MATERIALS AND METHODS
###end title 36
###begin title 37
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 37
###begin p 38
###xml 2 5 2 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 51 53 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 263 266 263 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
###xml 939 943 <span type="species:ncbi:10090">mice</span>
###xml 958 962 <span type="species:ncbi:10090">mice</span>
###xml 1039 1044 <span type="species:ncbi:10090">mouse</span>
D6-/- mice were generated as previously described (15). Homogeneous populations were established by backcrossing heterozygous mice to C57BL/6 mice for more than eight generations. The resultant heterozygous mice were bred to obtain homozygotes. WT C57BL/6J and D6-/- mice were bred in a specific pathogen-free/viral antibody-free barrier facility and obtained from Charles River Laboratories. 8-14-wk-old male and female mice were used in accordance with institutional guidelines in compliance with national (D.L. N.116, Gazzetta Ufficiale della Repubblica Italiana, supplement 40, 18-2-1992) and international law and policies (European Economic Community Council, 1987, Directive 86/609, Official Journal of European Communites L 358,1; and Institute of Laboratory Animal Resources, Committee on Life Sciences, National Research Council, 1996, Guide for the Care and Use of Laboratory Animals). Each experimental group consisted of 7-10 mice. All infected mice were maintained under germ-free conditions and were routinely monitored for mouse pathogens. Experiments were performed in specific pathogen-free facilities.
###end p 38
###begin title 39
Chemicals and reagents.
###end title 39
###begin p 40
All chemicals were purchased from Sigma-Aldrich, unless otherwise noted. Middlebrook 7H9 liquid medium and 7H10 agar were obtained from Difco Laboratories. Antibodies used in flow cytometry were obtained from BD Bioscience or R&D Systems.
###end p 40
###begin title 41
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
M. tuberculosis and infection of mice.
###end title 41
###begin p 42
###xml 43 58 43 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 150 165 149 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 334 349 333 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 529 532 526 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 593 594 588 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 664 679 659 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 884 886 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 43 64 <span type="species:ncbi:83332">M. tuberculosis H37Rv</span>
###xml 150 165 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 334 349 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 411 416 <span type="species:ncbi:10090">mouse</span>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
###xml 664 679 <span type="species:ncbi:1773">M. tuberculosis</span>
Mice were infected via the i.n. route with M. tuberculosis H37Rv (2 x 103 CFU in 20 mul). This resulted in reproducible delivery of 50-100 viable CFU M. tuberculosis, as confirmed by CFU determination on the lungs of infected mice 1 d after infection. In fact, in a total of 10 mice per group from four independent experiments, day 1 M. tuberculosis CFU ranged from 50 to 100 (with only one exception in one WT mouse of 110 CFU), and in any case no statistical significant differences between day 1 CFU in WT (72.5 +/- 21) and D6-/- (75 +/- 19) mice were detected (P = 0.9658 by the Student's t test). Moreover, using the i.n. infection route, we failed to detect M. tuberculosis CFU in nasal tissues in two different experiments. The tissue bacillary load was quantified by plating serial dilutions of the lung, liver, and spleen homogenates into 7H10 agar, as described previously (34).
###end p 42
###begin title 43
Flow cytometric analysis of tissue cells.
###end title 43
###begin p 44
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 1041 1046 <span type="species:ncbi:10090">mouse</span>
To determine cellular infiltrate, the lungs, liver, and mediastinal lymph nodes were removed at different weeks after infection and digested in the presence of 200 U/ml of collagenase, and mononuclear cell suspensions were obtained through Lympholyte M (Cederlane Laboratories) gradient centrifugation. The viability of cells, as determined by Trypan blue exclusion, was >90%. A single-cell suspension was prepared by pushing the tissue through a cell strainer. In some experiments, lung mononuclear cells were enriched in T cells by passage through a nylon wool column, and CD4 and CD8 T cells were then sorted by anti-CD4 or -CD8 immunomagnetic beads (Miltenyi Biotec), according to the manufacturer's instructions (34). The cells were incubated for 24 h at 37degreesC in complete medium to allow cells and beads to dissociate. Single-cell suspension were counted. The samples were triple stained with fluorochrome-conjugated anti-CD3, -CD4, -CD8, -CD44, -CD62L, -CD25, -CD11c, and -F4/80, in FACS buffer (0.1% Na azide, 0.1% BSA, and 20% mouse serum). Purified or PE-, FITC-, CyChrome-, or allophycocyanin-conjugated isotype control Igs were used as controls. After washes, the cells were fixed in 4% paraformaldehyde for 1 h and collected on a FACSCalibur (BD Biosciences). Analysis was performed on CellQuest software (BD Biosciences).
###end p 44
###begin title 45
ELISPOT analysis for IFN-gamma.
###end title 45
###begin p 46
###xml 20 22 20 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 199 201 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
The ELISPOT method (35) was used to detect IFN-gamma secretion by individual CD4 or CD8 T cells from infected mice, after stimulation with BCG-infected DCs in vitro prepared as previously described (36). In brief, ELISPOT plates (BD Biosciences) were coated with IFN-gamma capture antibody overnight at 4degreesC. The capture antibody was discarded, and the plates were washed and blocked with complete media for 2 h at room temperature. 150,000 purified CD4 or CD8 T cells per well were cultured with irradiated BCG-infected WT DCs for 36-40 h at 37degreesC. The cells were discarded, and plates were washed with deionized water and PBS/Tween 20. Secondary biotinylated antibody was added for 2 h and incubated at room temperature, followed by washing with PBS/Tween 20. Streptavidin-alkaline phosphatase was added to the plates for 1 h, followed by washing and development of a color reaction using the AEC substrate reagent kit (BD Biosciences). The reaction was stopped when spots developed by running the plate under water. The spots were enumerated using an ELISPOT reader (Bioreader 3000; BioSys).
###end p 46
###begin title 47
ELISA for cytokines and chemokines.
###end title 47
###begin p 48
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
BAL was obtained by flushing 2 ml PBS into the lungs of killed mice (37). The concentrations of chemokines (CCL2/MCP-1, CCL3/MIP-1alpha, CCL4/MIP-1beta, CCL5/RANTES, CCL11/eotaxin, and CCL22/MDC) and cytokines (TNF-alpha and IFN-gamma) were quantified by ELISA in BAL and sera using commercially available kits (R&D Systems).
###end p 48
###begin title 49
Determination of serum transaminases, BUN, and proteinuria.
###end title 49
###begin p 50
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 793 795 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
Serum alanine aminotransferase (ALT; EC 2.6.1.2) and aspartate aminotransferase (AST; EC 2.6.1.1) were measured by the standard photometric method using an automatic analyzer (type 7350; Hitachi Chemical Diagnostics) and a commercial kit (Sigma-Aldrich) adapted to small-sample volumes, as previously described (38). The normal ranges of ALT and AST were obtained testing sera from 10 mice, age- and sex-matched with animals used in experimental groups (38). Proteinuria was measured on a 0-4+ scale using a colorimetric assay strip (38) for albumin (Albustix; Bayer): 0, absent; 1+, </=30 mg/100 ml (mild); 2+, 100 mg/100 ml (moderate); 3+, 300 mg/100 ml (severe); and 4+, >2,000 mg/100 ml (severe). BUN levels were measured by impregnating Azostix strips (Bayer) with a drop of fresh blood (38) and using the following scale: 1+, 5-15 mg/100 ml (normal); 2+, 15-26 mg/100 ml (mild); and 3+, >/=30 mg/100 ml (severe).
###end p 50
###begin title 51
Neutralization of chemokines in vivo.
###end title 51
###begin p 52
###xml 301 303 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 305 307 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 745 760 733 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 70 74 <span type="species:ncbi:9925">goat</span>
###xml 310 314 <span type="species:ncbi:10090">Mice</span>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
###xml 542 546 <span type="species:ncbi:10090">mice</span>
###xml 627 631 <span type="species:ncbi:9925">goat</span>
###xml 668 672 <span type="species:ncbi:10090">Mice</span>
###xml 745 760 <span type="species:ncbi:1773">M. tuberculosis</span>
To block inflammatory chemokines, mice were treated with a mixture of goat antibodies to the CC chemokines CCL2/MCP-1, CCL3/MIP-1alpha, and CCL4/MIP-1beta), and a monoclonal antibody to CCL5/RANTES purchased lyophilized from R&D Systems, resuspended in sterile PBS, and mixed as previously described (16, 18). Mice were given i.p. injections of 200 mul of the mixture, equivalent to 100 mug of each antibody. Alternatively, mice were treated with 400 mug of individual antibodies specific for a single CC chemokine. On the same days, control mice received i.p. injections equivalent to 400 mug of irrelevant antibodies (normal goat IgG; Sigma-Aldrich) in 200 mul PBS. Mice were injected weekly, starting from the third week after infection with M. tuberculosis.
###end p 52
###begin title 53
Histology and morphometry.
###end title 53
###begin p 54
Tissue samples for histological studies were fixed in 10% normal buffered formalin, followed by paraffin embedment. 5-6-mum sections were stained with hematoxylin and eosin. For histometry, 5-mum-thick sections from each specimen were stained with hematoxilin and eosin and photographed at 6x using a stereoscopic zoom microscope (SMZ800; Nikon) and a digital camera (Coolpix 990; Nikon). Sections of at least eight lung lobes were studied in each case. A sequence of appropriate software programs were used (Scion Image [Scion Corporation]; Photoshop 5.0 [Adobe Systems Inc.]) to determine the area of each single lesion and the total tissue area on photomicrographs at each time point. Measurements were done blindly by two independent pathologists (P.J. Cardona and N. Caceres). Data are percentages calculated by dividing the granuloma-involved area by the global tissue area and multiplying by 100.
###end p 54
###begin title 55
Statistics.
###end title 55
###begin p 56
###xml 28 29 28 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 225 228 225 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 273 275 273 275 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10</sub>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
The double-tailed Student's t test was used to compare the significance of differences between groups. Kaplan-Meier analysis was used to determine the statistical significance of the differences in survival times of WT and D6-/- mice. The significance of differences of log10 CFU counts between groups was determined using one-way analysis of variance (ANOVA), with Scheffe tests for post-ANOVA individual comparisons. P < 0.05 was considered significant.
###end p 56
###begin title 57
Online supplemental material.
###end title 57
###begin p 58
###xml 58 73 58 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 207 222 207 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 281 284 281 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 58 73 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
###xml 186 191 <span type="species:ncbi:10090">mouse</span>
###xml 207 222 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows lung and draining lymph nodes sections from M. tuberculosis patients stained for D6 and the macrophage marker CD68. Fig. S2 shows expression levels of the D6 transcript in mouse tissues during M. tuberculosis infection. Table S1 reports the effects of treatment of D6-/- mice with anti-CC chemokine antibodies. Online supplemental material is available at .
###end p 58
###begin title 59
Supplementary Material
###end title 59
###begin title 60
[Supplemental Material Index]
###end title 60
###begin p 61
This study was carried out with financial support from the European Union FP6 contracts LSHP-CT-2003-503240 (MUVAPRED), LSHB-CT-2005-518167 (INNOCHEM), and LSHG-CT-2005-005203 (MUGEN); the CARIPLO Foundation (NOBEL project); the Ministero dell'Istruzione, Universita e Ricerca (FIRB project); and the Universities of Palermo and Milan (FIRST projects). This work was conducted with the support of the Fondazione Humanitas per la Ricerca and Italian Association for Cancer Research.
###end p 61
###begin p 62
The authors have no conflicting financial interests.
###end p 62

